← SynDRA
Urolithin A
SynDRA canonical compound SYN1078516 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Mechanism of action | antioxidant |
Mechanisms of action (all sources)
Cross-references
Synonyms
- 3,8-dihydroxy-6H-benzo[c]chromen-6-one
- 3,8-Dihydroxyurolithin
- 6H-Dibenzo[b,d]pyran-6-one, 3,8-dihydroxy-
- 3,8-dihydroxybenzo[c]chromen-6-one
- 3,8-Hydroxydibenzo-alpha-pyrone
- Mitopure
- ILJ8NEF6DT
- 6H-Dibenzo(b,d)pyran-6-one, 3,8-dihydroxy-
- 3,8-DIHYDROXYBENZO(C)CHROMEN-6-ONE
- 3,8-dihydroxy-6H-benzo(c)chromen-6-one
- RefChem:193319
- DTXCID3073185
- 3,8-dihydroxy-6h-dibenzo[b,d]pyran-6-one
- 3,8-Dihydroxy-6H-dibenzo(b,d)pyran-6-one
- MFCD20275235
- Urolithin A?
- RIUPLDUFZCXCHM-UHFFFAOYSA-N
- Uro-A
- UNII-ILJ8NEF6DT
- 3,8-dihydroxy-urolithin
- Urolithin A [WHO-DD]
- SCHEMBL803408
- orb1300010
- SCHEMBL29368885
- SCHEMBL29401099
- CHEBI:168442
- HMS6018O08
- Urolithin A, >=97% (HPLC)
- EX-A4345
- s5312
- AKOS028108778
- 3,8-Dihydroxybenzo[c]chromen-6-oneEE
- CCG-266776
- CS-6305
- EBC-252133
- MSK183729-100M
- AC-31959
- DS-19328
- FD171109
Look up Urolithin A in the interactive SynDRA portal →